Demis Hassabis, chief of Google DeepMind, believes there's a 50% chance of achieving AGI within 5 years. AGI means ...

Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI.

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 million.

Google DeepMind’s spin-off Isomorphic Labs says it’s almost ready to begin human testing for AI-designed drugs. Built on the success of AlphaFold, the company aims to speed up drug development in ...

DeepMind boss Demis Hassabis believes AI as smart as humans might not be far off. Hassabis is at the forefront of the Google-owned AI lab's efforts to develop AGI. He made the comments at a Wall ...

Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling breakthroughs. Brands. ... which emerged from Google DeepMind in 2021, ...

Google DeepMind CEO Demis Hassabis heads Gemini and the company's AI push while gaining more power. Here's how he became ...

Google has announced the consolidation of its formerly separate AI research labs — Google Brain and DeepMind — into a new unit named Google DeepMind. The new team will spearhead groundbreaking ...

Google DeepMind’s table tennis robot plays at an amateur human level, winning 45% of games against human opponents. The robot’s learning is enhanced through simulation and real-world data ...

An artificial intelligence system built by Google DeepMind, the tech giant’s primary artificial intelligence lab, has ...

Google's artificial intelligence company DeepMind has developed a breakthrough AI system that learns in a similar way to a human in order to prevent "catastrophic forgetting." ...